Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism.
暂无分享,去创建一个
M. Carini | G. Vannelli | G. Forti | M. Marini | L. Vignozzi | A. Morelli | S. Filippi | M. Maggi | R. Mancina | B. Fibbi | A. Chavalmane | Enrico Silvestrini
[1] M. Averbeck,et al. Androgen replacement in men undergoing treatment for prostate cancer. , 2008, The journal of sexual medicine.
[2] A. Traish,et al. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. , 2008, Journal of andrology.
[3] A. Burnett,et al. Cavernous nerve injury using rodent animal models. , 2008, The journal of sexual medicine.
[4] Wadih Arap,et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. , 2008, The New England journal of medicine.
[5] L. Levine,et al. Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized double-blind placebo-controlled trial. , 2008, The journal of sexual medicine.
[6] J. Benites,et al. Time course of endocrine changes in the hypophysis-gonad axis induced by hypobaric hypoxia in male rats. , 2008, The Journal of reproduction and development.
[7] G. Forti,et al. Which patients with sexual dysfunction are suitable for testosterone replacement therapy? , 2007, Journal of endocrinological investigation.
[8] Anthony V D'Amico,et al. Erectile function outcome reporting after clinically localized prostate cancer treatment. , 2007, The Journal of urology.
[9] Run Wang. Penile rehabilitation after radical prostatectomy: where do we stand and where are we going? , 2007, The journal of sexual medicine.
[10] J. Mulhall,et al. Penile rehabilitation should become the norm for radical prostatectomy patients. , 2007, The journal of sexual medicine.
[11] G. Vannelli,et al. Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat , 2007, International Journal of Impotence Research.
[12] M. Sarosdy. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy , 2007, Cancer.
[13] A. Traish,et al. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. , 2006, The journal of sexual medicine.
[14] C. Crescioli,et al. ORIGINAL RESEARCH—BASIC SCIENCE: Effect of Chronic Tadalafil Administration on Penile Hypoxia Induced by Cavernous Neurotomy in the Rat , 2006 .
[15] Xin-hua Zhang,et al. Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. , 2006, The journal of sexual medicine.
[16] L. Vignozzi,et al. Peripheral regulatory mechanisms in erection. , 2005, International journal of andrology.
[17] F. Montorsi,et al. Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. , 2005, The journal of sexual medicine.
[18] Philip S Li,et al. The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate. , 2005, The journal of sexual medicine.
[19] F. Montorsi,et al. Vardenafil for the treatment of erectile dysfunction: a critical review of the literature based on personal clinical experience. , 2005, European urology.
[20] G. Vannelli,et al. Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. , 2005, European urology.
[21] F. Montorsi,et al. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. , 2005, Molecular human reproduction.
[22] P. Agarwal,et al. Testosterone replacement therapy after primary treatment for prostate cancer. , 2005, The Journal of urology.
[23] L. Levine. Erectile dysfunction following treatment of prostate cancer: new insights and therapeutic options , 2004 .
[24] J. Kaufman,et al. Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men. , 2004, The Journal of urology.
[25] F. Montorsi,et al. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. , 2004, The Journal of urology.
[26] M. Giorgi,et al. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. , 2004, Endocrinology.
[27] S. Gelmini,et al. Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility. , 2004, Endocrinology.
[28] K. Bennewith,et al. Orally administered pimonidazole to label hypoxic tumor cells. , 2002, Cancer research.
[29] P. Lavie,et al. Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. , 2002, The Journal of clinical endocrinology and metabolism.
[30] F. Trimarchi,et al. Sexual inactivity results in reversible reduction of LH bioavailability , 2002, International Journal of Impotence Research.
[31] W. Catalona,et al. Quality‐of‐life outcomes for men with prostate carcinoma detected by screening , 2000, Cancer.
[32] R A Stephenson,et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. , 2000, JAMA.
[33] K. Syrjala,et al. Prevalence and predictors of sexual dysfunction in long-term survivors of marrow transplantation. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] J. Raleigh,et al. Identification of nonproliferating but viable hypoxic tumor cells in vivo. , 1998, Cancer research.
[35] D. Chan,et al. Influence of radical prostatectomy on serum hormone levels. , 1998, The Journal of urology.
[36] RB Moreland,et al. Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence , 1998, International Journal of Impotence Research.
[37] F. Montorsi,et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. , 1997, The Journal of urology.
[38] R H Brook,et al. Quality-of-life outcomes in men treated for localized prostate cancer. , 1995, JAMA.
[39] I. Goldstein,et al. Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection. , 1993, The Journal of clinical investigation.
[40] A W Partin,et al. The rat as a model for the study of penile erection. , 1989, The Journal of urology.
[41] D. Rodbard,et al. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. , 1978, The American journal of physiology.
[42] C. Huggins,et al. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate , 1941, CA: a cancer journal for clinicians.
[43] D. Bodurka,et al. Quality of Life and Sexual Functioning , 2006 .
[44] Adrian L. Harris,et al. Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.
[45] S. Pignata,et al. Quality of life: gynaecological cancers. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.